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Abstract
Connections from hippocampus to septal nuclei have been implicated in memory loss and the
cognitive impairment in Down syndrome (DS). We trace these connections in living mice by
Mn2+ enhanced 3D MRI and compare normal with a trisomic mouse model of DS, Ts65Dn. After
injection of 4 nl of 200 mM Mn2+ into the right hippocampus, Mn2+ enhanced circuitry was imaged
at 0.5, 6, and 24 hr in each of 13 different mice by high resolution MRI to detect dynamic changes
in signal over time. The pattern of Mn2+ enhanced signal in vivo correlated with the histologic pattern
in fixed brains of co-injected 3kD rhodamine-dextranamine, a classic tracer. Statistical parametric
mapping comparing intensity changes between different time points revealed that the dynamics of
Mn2+ transport in this pathway were surprisingly more robust in DS mice than in littermate controls,
with statistically significant intensity changes in DS appearing at earlier time points along expected
pathways. This supports reciprocal alterations of transport in the hippocampal-forebrain circuit as
being implicated in DS and argues against a general failure of transport. This is the first examination
of in vivo transport dynamics in this pathway and the first report of elevated transport in DS.
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Introduction
Down syndrome, trisomy 21, is the most frequent genetic cause of mental retardation (Epstein,
1986,Korenberg et al., 1994). A mouse model of Down syndrome (DS), the partial trisomic
Ts65Dn, has been extensively characterized with respect to deficits in behavioral measures for
learning and memory, histopathology of the brain, and functional parameters (Davisson et al.,
1990,Davisson et al., 1993,Reeves et al., 1995,Olson et al., 2004,Roper and Reeves,
2006,Seregaza et al., 2006). As in human DS, Ts65Dn mice display decreased cholinergic
neuron density in the medial septal nucleus (MSN) of the forebrain (Holtzman et al.,
1996,Cooper et al., 2001,Salehi et al., 2003,Delcroix et al., 2004), as well as over-expression
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of genes encoded on the excess chromosomal segment (Holtzman et al., 1996,Hunter et al.,
2003,Seo and Isacson, 2005).
Reciprocal connections link neurons in the forebrain with those in the hippocampus. Neurons
with cell bodies in the forebrain, including glutaminergic, GABAergic and cholinergic neurons,
send processes to the hippocampus (Amaral and Kurz, 1985,Gaykema et al., 1991,Alonso et
al., 1996,Risold and Swanson, 1996,Risold and Swanson, 1997,Colom, 2006) and
hippocampal pyramidal neurons innervate the septum (Wu et al., 2000). Transport within these
processes is thought to be important for neuronal functioning and survival (Stokin et al.,
2005). When radiolabeled nerve growth factor (NGF) is injected into the hippocampal region,
less arrives in the forebrain in Ts65Dn mice compared to wildtype littermates (Cooper et al.,
2001). This has been attributed to decreased retrograde transport in TrkA expressing
cholinergic neurons and thus is proposed to underlie the cholinergic neuronal atrophy in these
mice. Treatment with NGF by intracerebroventricular injection in Ts65Dn mice, nonhuman
primates, and Alzheimer's patients results in recovery of basal forebrain cholinergic cells
expressing the NGF receptor, TrkA (Tuszynski et al., 1990,Cooper et al., 2001,Tuszynski et
al., 2005). Thus, decreased transport of NGF from hippocampus to forebrain may play a
significant role in DS, although direct imaging of such transport is lacking. Recent work also
implicates transport in this pathway as a causative factor in Alzheimer's disease, where axonal
varicosities presumed to represent transport blockages were found in cholinergic neurons
projecting from septum to hippocampus (Stokin et al., 2005). Taken together these results
suggest that generalized defects in transport may result in cognitive dysfunction and neuronal
degeneration.
Here we test whether connections from the hippocampus to the forebrain are altered in DS
mice. We use Mn2+ enhanced magnetic resonance imaging (MEMRI) to image this circuit in
living DS mice and their normal 2N littermates. Mn2+ is a T1 MR contrast agent that enters
neurons through calcium channels (Merritt et al., 1989), is carried down the axon primarily by
anterograde transport (probably via transport vesicles), and crosses synapses (Lin and
Koretsky, 1997,Pautler et al., 2003,Silva et al., 2004). In the macaque, stereotaxic co-injection
of Mn2+ and the classic histologic tracer, wheat germ agglutinin conjugated to horse radish
peroxidase, yielded the same highly specific projection pattern (Saleem et al., 2002,Murayama
et al., 2006), further demonstrating the usefulness of Mn2+ as a trans-synaptic tracer of neuronal
connections.
We injected nanoliter volumes of Mn2+ into a precise location in the right hippocampus of 7
Ts65Dn and 6 2N littermates and imaged the living mice by MR at 0.5, 6 and 24 hr afterwards.
To obtain statistically reliable information, we performed 3-dimensional statistical analyses of
Mn2+-induced changes of intensity over time. First images obtained at the same time point
from all mice in either the Ts65Dn or 2N littermates group were warped into one 3D space
(Lancaster et al., 2003,Kovacevic et al., 2005,Lee et al., 2005). By taking the average intensity
of each voxel from all warped images in each group a single averaged 3D image for each
genotype at each time point was generated. Datasets from two different time points were
compared using the paired Student's t-test to identify those voxels whose intensity changed
significantly between time points. Co-injection of the classical histological tracer, 3kD
rhodamine-dextran-amine (RDA), followed by post-mortem microscopic analysis confirmed
our MR methodology. In contrast to studies showing decreased NGF transport in DS mice, we
find robust transport in these mice of these general tract tracers. Similarities in the molecular
machinery used in anterograde and retrograde transport allows us to draw conclusions about
general transport dysfunction in the DS mouse.
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Material and Methods
Animals
Nine to eleven month old Ts65Dn mice and 2N littermates were obtained from Jackson Labs
(Bar Harbor, ME). Seven Ts65Dn (trisomic) and six 2N littermates (wildtype) mice were
employed in this study. All mice were male. Genotypes were confirmed by Cecilia Schmidt
(Jackson Labs) by quantitative PCR (Liu et al., 2003). All animal experiments conformed to
National Institutes of Health guidelines and were approved by the California Institute of
Technology Animal Care and Use Committee.
Stereotaxic Injection
Calibrated micropipettes were used to attain consistent injection volumes. The micropipettes
were fashioned from 1 mm OD quartz capillary pulled to approximately 40μm ID bore near
the tip with a Sutter Instruments (Novato, CA) P-2000 micropipette puller. The identical
program was used to pull all micropipettes. Micropipettes were calibrated by drawing a 4mm
length of the MnCl2/RDA solution (see below) into the end of the micropipette using a World
Precision Instruments Inc. (Sarasota, Florida) microsyringe pump with digital display driving
a 10μl syringe fitted to the micropipette via oil-filled 0.01”ID PEEK™ (polyetheretherketone)
tubing (Upchurch Scientific Inc, Oak Harbor, WA). The total solution volume was slowly
ejected into a small amount of oil on a hemocytometer using the microsyringe pump, and the
volume of the spherical drop determined from measurement of its diameter. Performing this
procedure with six different micropipettes yielded a volume of 4.3±0.6 nl (average ± standard
deviation) for the delivered material. The same apparatus and filling/ejection procedure was
used for stereotaxic injections.
Ts65Dn and 2N littermate mice were anesthetized with ketamine/xylazine (7.5mg ketamine
plus 5mg xylazine per kg, i.p) and placed in a stereotaxic frame (Kopf Instruments, Tujunga,
CA). 4.3 nl of 200 mM MnCl2 with 0.5 mg/ml RDA (3k) (Molecular Probes/Invitrogen,
Eugene, OR) was injected unilaterally into the right hippocampus (coordinates x –3.2 mm
(midline), y -4.1 mm (Bregma), z 3.4 mm (down) (Paxinos and Franklin, 2001)) over 5 minutes
using the microsyringe pump and calibrated micropipette in a modified procedure (Bearer et
al., 2000,Jaffe and Terasaki, 2004). After injection, the capillary was left in place for 3-5
minutes and withdrawn over 5 minutes. Animals were injected and imaged over a 3 week time
period in random order.
Following injection, the animal was immediately placed in the MR scanner under 0.8%
isoflurane anesthetic. Inspection of MR images recorded 0.5 hr after injection revealed that the
average injection site (center of the small hypointense region) for the Ts65Dn mice was: x
(lateral) +3.43±0.37 mm; y (A-P), -3.55±0.4 mm, z (D-V) -4.07±1.5 mm; and for 2N littermates
was: x, +3.27±0.22 mm; y, -4.23±0.23 mm; z, -3.05±0.26 mm.
Magnetic Resonance Imaging
An 11.7T 89 mm vertical bore Bruker BioSpin Avance DRX500 scanner (Bruker BioSpin Inc,
Billerica, MA) equipped with a Micro2.5 gradient system was used to acquire in vivo mouse
brain images with a 35 mm linear birdcage RF coil. The animal's head was secured in a Teflon
stereotaxic unit within the RF coil to minimize movement and aid in reproducible placement.
Temperature and respiration were continuously monitored during data acquisition and
remained within normal ranges. We employed a 3D RARE imaging sequence (Hennig et al.,
1986) with RARE factor of 4, 4 averages, TR/TEeff = 300ms/21ms; matrix size of
256×160×128; FOV 23 mm × 14.4 mm × 11.5 mm; yielding 90 μm isotropic voxels with 102
minutes scan time. Images were recorded from each mouse before (1-5 days) and after injection
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(0.5 hr, 6 hr, and 24 hr). All 13 mice (7 Ts65Dn and 6 2N littermates) were imaged at each of
these 4 time points.
Histology
One day to 3 weeks after in vivo MR imaging, each mouse was anesthetized, sacrificed and
fixed by transcardial perfusion with a 30 ml washout with warm heparinized phosphate
buffered saline (PBS) followed by 30 ml of room temperature 4% paraformaldehyde (PFA) in
PBS at a rate of 5 ml/min. The carcass was decapitated and the head rocked in 4% PFA in PBS
overnight at 4°C. Brains dissected from the calvarium were sent to Neuroscience Associates
(NSA, Knoxville, TN) for gelatin embedding, frozen sectioning at 35 μm and staining.
Alternate sections were selected for staining with either Thionine/Nissl for cellular
morphology, or immunohistochemistry for anti-choline acetyl transferase (ChAT), a relatively
specific marker for cholinergic neurons, or for mounting unstained in anti-quench (Vector Lab,
Burlingame, CA) to image the RDA fluorescence. Sections were imaged on a Zeiss Axioscope
equipped with 5×, 10×, 20×, 40×, 63× and 100× neofluor objectives and captured by an
Axoicam MRM. The number of ChAT positive neurons in the MSN was obtained from three
trisomic and three 2N littermates embedded in the same gelatin block and sectioned in parallel
simultaneously in register. Four sections traversing the MSN were selected for counts, and all
six brains were counted in each section. The anterior commissure was used as a landmark to
confirm equivalency of the position of the section for each brain along the A-P axis. More than
1,000 cells were counted for each animal.
Image Processing and Derivation of Statistical Parametric Maps
MR image data was converted to Analyze 7.5 format (Mayo Clinic, Rochester, MN) modified
to be readable in SPM2 (Wellcome Department of Imaging Neuroscience, University College
London). SPM2 was used for all statistical comparisons in a manner similar to Cross and
coworkers (Cross et al., 2004). After bias correction in SPM2, each was scaled to the mode of
its intensity histogram (Kovacevic et al., 2005). Initially, one of the wildtype pre-injection
images was chosen as a template and all 52 images (all animals at all time points) were
normalized to it using an affine transformation and interpolated to 50μm voxel size. The
average of the normalized pre-injected images from the wildtype group and from the DS group
were each calculated and used as template images for their respective groups; removing bias
due to selection of any individual image as template (Kovacevic et al., 2005,Lee et al., 2005).
Pre-injected DS and 2N brain images were then normalized to their respective averages using
full nonlinear normalization. The nonlinear transformation used to drive each individual
mouse's pre-injected scan into its template was re-applied to drive that mouse's 0.5, 6, and 24
hr scans into the same coordinate system. Images were smoothed to 300μm and paired Student's
t-tests performed comparing the different time points within each group, providing t-value and
corresponding p-value maps of significant differences. The averaged images shown in Figures
3, 5 and 6 represent the arithmetic mean of each voxel in the smoothed DS or 3N littermate
individual images.
Computational Rendering:
Visualization of the MR images and statistical parametric maps was performed with
ResolveRT4 (Mercury Computer Systems, Inc., Hudson, NH) and MRIcro (Rorden and Brett,
2000).
Volumetric analysis of enhanced voxels:
For each of the 13 half hour data sets, the number of voxels within injection site halo were
determined using the 3D ROI feature in MRIcro. The halo was defined as contiguous voxels
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around the injection site with intensity greater than the mean unenhanced parenchyma intensity
plus 3 times the background noise level.
The 3D maps of voxels with significantly increased intensity between each pair of images (0.5
hr versus preinjection, 6 versus 0.5 hr, and 24 versus 6 hr) were used to determine the volume
of brain displaying Mn2+ enhanced signal in each group. The number of voxels within a defined
anatomical region whose intensity was enhanced (p<0.0005) was computed using MRIcro.
Results
The Ts65Dn genotype was confirmed by PCR and the phenotype by histologic examination
of individual mice fixed by perfusion after MRI (Fig. 1). Ts65Dn mice displayed the expected
morphological phenotype of decreased cell numbers and loss of cholinergic neurons in the
septal nuclei (Fig. 1), as previously reported (Granholm et al., 2000,Cooper et al., 2001,Seo
and Isacson, 2005). Histological examination revealed qualitative decreases in the number and
size of cells in the septal nuclei of DS mice as compared to 2N littermates (Fig. 1A and B).
Immunohistochemistry with anti-choline acetyl transferase (ChAT) demonstrated diminished
numbers of cholinergic neurons in the medial septal nuclei (MSN) of DS mice versus 2N
littermates (Fig. 1C). In six of the mice, counts of ChAT positive nuclei in histologic sections
spanning the MSN demonstrated a 30 ± 5% decrease in the number of neurons in DS versus
2N littermates. ChAT-positive neuronal cell bodies found in the MSN of DS brains also
appeared shrunken compared to the plump cell bodies in littermates. No obvious differences
in thickness or number of fibers in the hippocampal commissure, fimbria, or fornix were
observed in histological sections. Thus, the aging Ts65Dn mice used in this study displayed
the expected morphological abnormalities previously described for these mice, features similar
to those found in human Alzheimer's disease and Down syndrome.
Injection site analysis by correlation of optical and MR microscopy
Co-injection of the tracer, RDA, with the Mn2+ allowed us to correlate the injection site in
histologic sections with MR images of the same individuals. Imaging by combined phase and
fluorescent microscopy of unstained gelatin-embedded sections of brains fixed immediately
after acquisition of the last MR image (24 hr) identified the precise location of the injection
(Fig. 2). In animals fixed 6 days after injection, no needle track or tissue damage at the injection
sites were identified.
Comparison of MR images captured 0.5 hr after injection demonstrated that the injection
position was accurately and reproducibly placed in all the mice studied (Fig. 3). The epicenter
of the injection site (±200μm diameter), containing the highest concentration of Mn2+, appears
hypointense (dark) in MR images at this early time point because the level of Mn2+ there was
sufficient to produce significant T2-shortening and concomitant darkening (Lee, 1991).
Analysis of the 3D location of this epicenter in each of the 13 animals demonstrated that among
all animals injections were routinely placed in CA3 of the hippocampus (see Materials and
Methods).
At 0.5 hr post injection, the hypointense injection site was surrounded by a white halo of
hyperintensity indicating passive diffusion of the Mn2+ ion outward from the injection site.
The halo volume was found to be 9.3±1.9 μl for the Ts65Dn cohort and 9.0±1.4 μl for the 2N
littermates. An equivalent spherical volume would have a radius of 1.3 mm. Such diffusion is
a common factor in all studies employing water-soluble low molecular weight tracers. Previous
studies in the songbird, mouse, rat, minipig, and macaque note the same initial Mn2+ diffusion
with no lack of specificity of subsequent projection patterns (Saleem et al., 2002,Van der
Linden et al., 2002,Leergaard et al., 2003,Pautler et al., 2003,Van der Linden et al.,
2004,Watanabe et al., 2004b,Jelsing et al., 2006,Murayama et al., 2006). Presumably, only
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neurons in the immediate vicinity of the high Mn2+ concentration take up enough Mn2+ for
detection after transport to distant sites. To focus the high concentration of Mn2+ in as small a
brain region as possible, the volume of Mn2+ injected in this study (4.3 nl) was 10-1000 times
less than that employed in previous studies. The reproducible placement of the injection sites
and the comparable size of the diffusion halo argue that consistent amounts of both tracers,
Mn2+ and RDA, were delivered to the same population of neurons in each animal tested. Thus,
comparisons between individual animals or across cohorts are not confounded by effects due
to different amounts of tracer introduced or different locations being probed.
Histological tract tracing demonstrated that the injection site was appropriate for uptake into
the hippocampal-forebrain circuit
Co-injection of RDA with the Mn2+ allowed tracing of fluorescence in histologic sections of
the same animals imaged by MR (Fig. 4). By comparing the patterns of distribution of Mn2+
and RDA, we confirmed that the placement of the injection site was appropriate for entry of
tracer into the hippocampal-septal connections, and that the transport within those connections
was operational. Small RDA such as the 3kD used here are taken up and moved inside neuronal
processes, either diffusively or primarily in the retrograde direction at slow rates. Diffusive
motion of small dextrans is observed in the squid axon (Terasaki et al., 1995) and 1-3 weeks
is required for studies of CNS pathways in adult rodents (Reiner et al., 2000,Van Haeften and
Wouterlood, 2000). In serial sections of brains fixed 6 days after injection, RDA was found
along the fimbria and fornix ipsilateral to the injection site but not detectable on the
contralateral, non-injected, side (Fig. 4A-C). At the level of the medial septal nucleus,
containing the cholinergic neurons that send processes to the hippocampus, RDA fluorescence
appeared on both sides of the midline (Fig. 4D).
These results confirm that the injection site in the hippocampus was positioned appropriately
for entry into the hippocampal-septal pathway. No other locus with detectible accumulation of
RDA was found. These results did not reveal any obvious difference in RDA fluorescence
between DS mice and their 2N littermates in the fimbria, fornix or septal region. This is
consistent with reports of another retrograde tracer, Fluorogold, which was injected in CA3 of
the hippocampus in much higher quantities than in our study, and arrived into the MSN of
Ts65Dn and their littermates in similar amounts (Salehi et al., 2006).
Mn2+ enhanced signal appears in the septal region within 6 hours of injection
Qualitative assessment of MR slices taken at the level of the basal forebrain revealed a time-
dependent accumulation of Mn2+ in the septal nuclei after injection into the hippocampus (Fig.
5). These coronal slices were selected from 3D MR images at Bregma +0.4 mm position (see
Fig. 5A for diagram). In these averaged 3D images at 0.5 hr post-injection, no Mn2+ enhanced
brightness was seen in the septal region although slices through the injection site at Bregma
-4 .0 mm display Mn2+ enhancement as shown in Fig. 3. In contrast, by 6 hr the septal region
ipsilateral to the injection site appeared brighter and this persisted in the 24 hr image (Fig 5B).
Mn2+ enhancement in the septal region at 6 and 24 hr is qualitatively similar or greater in Ts65n
mice than in 2N littermates. Mn2+ enhanced signal also appeared in the contralateral
hippocampus at 24 hr as shown in coronal slices at the level of the dentate gyrus of the
hippocampus, Bregma -2.7 (Fig. 6). Again this enhancement was qualitatively similar or
greater in Ts65Dn than in 2N littermates.
Thus, Mn2+ was transported from the injection site in the hippocampus to the septum in
relatively short times and to the contralateral hippocampus within 24 hours. Transport from
the injection site to the septum required more than 0.5 hr and less than 6 hr to traverse the
distance of ∼6.5 mm (from injection site, along the fimbria, to septum); we thus calculate a
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transport rate from 0.3 to 3.6 μm/sec, consistent with fast axonal transport of 0.05-2 μm/sec
(Satpute-Krishnan et al., 2006).
Mn2+ is transported further faster in Ts65Dn mice than in normal littermates
SPM along with spatial realignment and normalization have become standard methodologies
for human brain imaging studies (Thompson and Toga, 1996,Thompson et al., 1997,Woods et
al., 1998,Hajnal et al., 2001,Toga and Thompson, 2001,Toga and Mazziotta, 2002,Lancaster
et al., 2003,Yoo, 2004). The same general procedures employed here have been used to make
‘standard atlas’ spaces for mouse brains of various strains and ages (MacKenzie-Graham et
al., 2004,Kovacevic et al., 2005,Lee et al., 2005). Despite significant anatomical abnormalities
(Baxter et al., 2000; Kurt et al., 2000; Olson et al., 2004), the brains of the Ts65Dn mice were
surprisingly similar structurally, and could be aligned into the same 3D space. However, these
Ts65Dn abnormalities precluded alignment of the mutant brains into the same template as their
anatomically normal littermate controls. We therefore pursued analysis of the circuits enhanced
by Mn2+ within each cohort and compared the resulting patterns between groups.
To identify dynamic changes in the anatomical pattern of Mn2+ enhancement over time after
injection, we used SPM to compare each subsequent dataset with that immediately preceding
it in the time series. Here we present three comparisons for each genotype: 0.5 hr post-injection
versus pre-injection (Fig. 7A), 6 hr versus 0.5 hr (Fig. 7B), and 24 versus 6 hr post-injection
(Fig. 7C). Those voxels with significantly (P<0.0005) increased signal intensity in the later
time point image are displayed as a colored voxel on the maps (Fig. 7).
In the 0.5 hr versus pre-injection comparisons (Fig. 7A), both sets of animals displayed similar
paired Student's t-test maps at P<0.0005. The injection site was in a similar position and of a
similar size in the posterior hippocampus in both cohorts. This result confirms the precise
position of the injection site and that the amount of Mn2+ injected was similar in all animals.
Relative lack of enhanced signal (colored voxels in Fig. 7A) outside the injection site attests
to the dependence of signal enhancement (at P<0.0005) on the presence of Mn2+ and to the
accuracy of the alignment.
Comparison of 6 hr versus 0.5 hr statistical maps demonstrated that Mn2+ followed the expected
route from the hippocampus through the fimbria to the basal forebrain in both DS and 2N
littermates (Fig. 7B). Voxels with statistically significant increased intensity were seen in both
normal and Ts65Dn cohorts in CA3, the fimbria (fi), the septofimbrial nucleus (Sfi), and the
LSN (Table 1). In the DS cohort more statistically significant voxels were found in these
structures and significant signal had progressed further along the expected pathways, appearing
already at 6 hours in the MSN, contralateral fimbria, as well as secondary olfactory structures
(dorsal portion of acumbens core, anterior olfactory nucleus, and dorsal tenia tecta; see Table
1).
Continued transport in these living mice during the 6 hr to 24 hr interval was revealed by SPM
comparisons of these two time points. In this case, only voxels whose intensity increased
between 6 hr and 24 hr are displayed (Fig. 7C). This comparison revealed that, by 24 hr in 2N
littermates, Mn2+ transport caught up to that seen at earlier time points in DS mice. Thus by
24 hr Mn2+ had progressed into the MSN in both sets of animals. By this time, both cohorts
also displayed voxels with significantly increased intensity in CA3 of the contralateral
hippocampus, and bed of nucleus stria terminalis (Table 1).
In addition, at 24 hr post-injection, the DS group again out-performed their 2N littermates,
displaying Mn2+ signal further rostrally along the hippocampal-forebrain pathway, with
statistically significant signal enhancement in the nucleus accumbens and areas within the
ventral pallidum; the ventromedial hypothalamus and the amygdala; and the anterior part of
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retrosplenal granular cortex (Fig. 7C and Table 1). Thus DS mice compared to 2N littermates
displayed voxels with statistically significant Mn2+ enhancement further along the
hippocampal-forebrain pathway at both 6 and 24 hr after injection.
Mn2+ enhanced signal occupies more volume along the hippocampal-forebrain tract in DS
mice than in littermates
Comparison of the total volume occupied by significantly enhanced voxels (P<0.0005) in the
statistical parametric maps of each set of animals demonstrated that DS had a larger volume
enhanced by Mn2+ than their 2N littermates (Fig. 8). In the map comparing the 6 hr to 0.5 hr
data (Fig. 7B), the volume of Mn2+ enhanced voxels in the basal forebrain occupied 2.4
mm3 in DS animals, but only 1.3 mm3 in 2N littermates. Mn2+ enhanced volumes at 24 hr in
the contralateral hippocampus were 3.1 mm3 and 0.2 mm3 in the DS and 2N littermates,
respectively. Thus, the extent of Mn2+ transport is greater (observed further along expected
tracts) and more robust (more volume affected) in DS mice as compared to 2N littermates.
Discussion
Here we show that Mn2+ injected into CA3 of the hippocampus dynamically traces the
hippocampal to septum pathway during the 24 hours after injection. Transport of Mn2+ from
hippocampus to basal forebrain is more robust in a trisomic mouse model of Down syndrome,
Ts65Dn, than in 2N littermates. The transport pattern of Mn2+enhancement measured in live
animals coincides with the pattern of a coinjected traditional tracer (RDA) measured in
histological sections. Histological examination revealed the typical DS phenotype of the DS
mice and little to no tissue damage by the injection was observed. Alignment and averaging
of MR images demonstrated the reliability of location and amount of injectate. Voxel-wise
paired Student's t-test analysis of co-registered brain images from 7 individual DS mice at
different times after injection revealed an unbiased comprehensive view of the time-course and
pattern of Mn2+ transport. Comparisons of SPM analyses of DS mice with 2N littermates
revealed that Mn2+ induced signal enhancement occupied more voxels and progressed more
quickly along expected pathways in Ts65Dn mice than in normal 2N littermates.
Manganese as a track tracer:
Mn2+, a calcium analogue, enters neurons and other cells through calcium and/or other divalent
ion channels (Merritt et al., 1989,Kwan and Putney, 1990,Fasolato et al., 1993,McColl and
Naccache, 1997) and is transported along neuronal pathways, even crossing synapses (Lin and
Koretsky, 1997,Pautler et al., 1999,Duong et al., 2000,Leergaard et al., 2003,Watanabe et al.,
2004a). Transport of Mn2+ is microtubule-dependent and primarily in the anterograde direction
(Sloot and Gramsbergen, 1994,Tjalve et al., 1995,Pautler et al., 1998) at speeds consistent with
fast axonal transport, suggesting that once in the cytoplasm, Mn2+ enters membrane-bound
organelles and is trafficked by normal vesicular transport mechanisms. Mn2+ tract tracing has
been used to reveal changes in neuronal circuitry in the songbird in response to endocrine
stimulation (Van der Linden et al., 2002,Van der Linden et al., 2004).
The degree of Mn2+ induced hyperintensity at a location distant from its initial placement is
dependent on at least three factors: 1) local uptake; 2) directed movement along/within the
neuronal connections (including initial packaging in the cytoplasm, microtubule-based
movement within processes, and possibly crossing synapses); and 3) accumulation at the
distant site. Operationally we use the term “transport” to encompass all three factors. Thus,
changes in transport (as evidenced by a greater or lesser amount of tracer found at the distant
site) can be due to modulation of any or all of these factors. Similar caveats pertain to all tract
tracers (e.g. radioactive or fluorescent) used to study neuronal projections. In addition to
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transport defects, DS mice may also have synaptic alterations that could effect Mn2+ uptake
(Schuchmann et al., 1998,Belichenko et al., 2004).
Retrograde versus anterograde transport:
The hippocampal to forebrain pathway contains neuronal processes emanating from either end.
In each type of neuron, both anterograde and retrograde transport carry endogenous cargo to
and from the cell bodies. Introduction of a traceable compound at one end of the circuit results
in its transport to the other end by either anterograde or retrograde intraneuronal trafficking.
Transport of NGF from the hippocampus to the basal forebrain is decreased in Down syndrome
mice of the same age as those used in this work (Cooper et al., 2001,Salehi et al., 2003). This
decrease is thought to be within cholinergic neurons whose cell bodies are in the MSN. Thus,
decreased delivery of NGF from an injection site in the hippocampus to the septum likely
reflects defects in local uptake and/or retrograde transport in these neurons. Our results suggest
that this decrease may be selective for NGF transport and not a result of generalized transport
deficits, since Mn2+ transport is at least as robust as in normal littermates. In support of this,
retrograde transport of Fluorogold, also a general tracer for retrograde connections, is also
apparently normal in these mice, although more difficult to quantify precisely (Salehi et al.,
2006).
In vivo Mn2+ enhanced MRI allows quantitative analysis of transport dynamics in living
animals:
MR imaging provided three advantages over traditional approaches to the study of transport
in the hippocampal to forebrain pathway. First, live animals could be imaged repeatedly,
thereby obtaining a sequential view of the process of transport along the pathway. Second,
three dimensional information is obtained in a holistic image acquired in one session, avoiding
the artifacts of fixation, embedding and sectioning and speeding data collection. Third,
quantitative analysis of pooled samples allows statistical significance across a cohort of
individuals to be obtained. Thus, more reliable information from living animals in three
dimensions with statistical power is possible with MRI.
SPM provides a comprehensive anatomically unbiased view of the time dependence of
Mn2+ transport in the DS and normal mice. This approach revealed that the entire pathway
from the hippocampus to the basal forebrain was enhanced at 6 hr compared to 0.5 hr post-
injection. The volume of enhancement in the basal forebrain was almost a factor of two larger
in trisomic versus normal animals; directly confirming the more robust character of transport
in this Down syndrome model. At 24 hr compared to 6 hr post-injection, the volume of
enhancement in the contralateral hippocampus is a factor of 12 larger in DS mice than normal
animals. Thus, these observations depict an overall increase in transport efficacy in the DS
mice, which also extends beyond the hippocampal to basal forebrain circuit to more distal
locations.
Axonal transport in neurological disease:
Evidence is accumulating that axonal transport plays a significant role in neuronal survival and
neurodegenerative diseases (Mandelkow et al., 2004,Morfini et al., 2005,Stokin et al.,
2005,Chevalier-Larsen and Holzbaur, 2006). Four mechanisms underlying altered transport
have been proposed (Goldstein, 2003,Salehi et al., 2004,Morfini et al., 2005): (1) blockage of
the path, (2) abnormal tracks, (3) defects in motor machinery, and (4) disrupted signaling.
Physical blockage of the axon lumen would hamper transport in both directions, as would
disruption of microtubule tracks or general motor defects. We thus exclude these three
possibilities as mechanisms to explain decreased transport of NGF in these mice, since we
observed more robust transport of Mn2+ in the DS mouse model, while retrograde transport of
low molecular weight RDA and Fluorogold transport both appear unchanged (Salehi et al.,
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2006). Secondly, both anterograde and retrograde motors (kinesin and dynein) use the same
microtubule track system, thus a general destabilization of tracks is inconsistent with current
observations concerning transport in the DS model. Our results do not rule out a selective defect
in NGF transport that may involve a defect in uptake, binding/linkage of NGF-bearing cargo
to the motor or signals that activate its transport.
Another plausible explanation for both more robust anterograde and selectively decreased
retrograde transport in DS mice could be that high APP levels increase affinity of transport
vesicles for anterograde motors at the expense of retrograde motors, thus altering the balance
between anterograde and retrograde transport (Salehi et al., 2006). Among the genes that are
triplicated in human Down syndrome is amyloid precursor protein (APP), a component of
senile plaques of Alzheimer's disease and recently implicated as a vesicular receptor for axonal
motor machinery (Satpute-Krishnan et al., 2006, Kamal et al., 2000, Kamal, 2001, Lazarov et
al., 2005). APP is among the genes that co-segregates with mental retardation in partial
trisomies in human (Korenberg et al., 1994). Ts65Dn mice also carry three copies of the APP
gene and over-express the protein (Salehi et al., 2006,Seregaza et al., 2006). The necessary
coordination of anterograde and retrograde transport (Martin et al., 1999,Gross et al.,
2002,Welte, 2004,Klumpp and Lipowsky, 2005) implies that effective movement of cargo
(e.g. NGF) could be disrupted without altering the detailed molecular mechanisms involved in
movement along tracks, but simply by disrupting the interaction(s) that coordinate
directionality.
Conclusion:
The use of Mn2+ as a transport tracer and longitudinal magnetic resonance imaging allowed
us to measure transport dynamics in vivo in individual animals. This revealed functional
differences in the hippocampal to forebrain pathway in a mouse model of Down syndrome.
Co-registration of images from a cohort of animals allows application of statistical methods
for unbiased evaluation of spatio-temporal changes in Mn2+ transport, revealing more robust
transport in the Down syndrome mouse. No other technology offers the ability to peer into the
living mammalian brain and determine physiological transport parameters. These results point
out that neuronal transport is a complicated phenomenon and that alterations in transport
dynamics can have important ramifications in cognitive functioning. Future application of this
powerful technology to earlier stages in DS and to other types of neuropathologies where
transport defects are implicated will undoubtedly provide more mechanistic insights.
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Figure 1. DS mice have fewer cholinergic neurons in the MSN
A. Examples of coronal histologic sections of Ts65Dn and 2N littermates at the level the MSN
(approximately Bregma +0.4−0.5) stained with thionine-Nissl. The MSN is the A-shaped
region in the center of the images indicated by dashed white lines. Note decreased cell density.
Bar = 100 μm.
B. Higher magnification of the central region of the MSNs shown in A above. Note the
decreased number of cell nuclei in Ts65Dn in this region of the brain. Bar = 40 μm.
C. Adjacent sections stained with anti-ChAT for immunohistochemistry showing decreased
numbers of cholinergic neurons in the MSN of DS compared to littermates. Bar = 200 μm.
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Figure 2. Injection site visualized in histologic sections showing lack of tissue damage
Shown is an example of the injection site as imaged by light microscopy in one of the mouse
brains perfusion fixed after the last MR imaging at 24 hr post-injection. In histologic sections
the injection site in the hippocampus was readily identified by the red fluorescence from the
co-injected RDA. Histological examination identified little tissue damage. Bar = 100 μm.
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Figure 3. Consistent placement of injection determined by MRI analysis
Coronal slices from 3D data sets showing the injection site (Bregma −4 mm) at 4 time points.
Left panel show slices from a single animal in each cohort (2N normal and DS). Right panel
shows the same slice taken from the averaged images at each time point. Subiculum (S, white
arrowhead) and dentate gyrus (DG, black arrowhead) of the hippocampus are noted in the lower
right panel. Bar = 500μm.
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Figure 4. Transport of 3kD rhodamine-dextran-amine, a traditional tract tracer, from
hippocampus to medial septum after co-injection with the Mn2+ into the right hippocampus
A. and B. Fluorescence microscopy of a coronal section through the hippocampus anterior to
the injection site (at Bregma −2.46). The tracks exiting the hippocampus in the fimbria/alveus
on the right side (B) show rhodamine fluorescence (arrows) but no fluorescence above
background is seen on the uninjected left side (A). Bar = 200 μm
C. Lower magnification showing fluorescence of the RDA on the right (arrow) but not left side
of the hippocampal commissure at the midline (Bregma –1.46 mm) of the same mouse brain
shown in A and B. Tracer is also not present in the cortical commissures, above (dorsal to) the
hippocampal fibers. Bar = 200 μm
D. Medial septal nuclei (Bregma +0.4 mm) also show rhodamine fluorescence indicating
transport of the RDA tracer to the septum. In this example, the 2N littermate brain was fixed
by perfusion 6 days after injection. Bar= 100 μm.
Bearer et al. Page 18
Neuroimage. Author manuscript; available in PMC 2008 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. Mn2+ is transported to the forebrain at 6 hours after hippocampal injection
A. Schematic showing the positions of the injection site in the hippocampus and of the septal
nuclei in the forebrain. Shown are 2 coronal slices within a semitransparent rendering of the
mouse brain. The view is from the front left side of the brain, anterior to the left, posterior to
the right. The slice at Bregma −4.0 mm (4 mm posterior to Bregma) is from the averaged
Ts65Dn 24hr data (see Figure 3) at the level of the injection site, which is indicated by a small
sphere within the hippocampus. The slice at Bregma 0.4 mm (0.4 mm anterior to Bregma) is
from the averaged 6 hr Ts65Dn data (see Figure 3) where Mn2+ hyperintensity is clearly visible
in the septal nuclei (LSN, lateral septal nuclei).
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B. MRI images (coronal sections) taken from the averaged 3D datasets at the level of the septal
nuclei (Bregma 0.4 mm) at 4 time points. The left panel shows slices from the 2N littermates
and right panel from the trisomics. All images are at the same spatial and intensity scales and
have been rendered identically. No changes are observed between the pre-injected image (top
row) and 0.5 hr after injection (2nd row). By 6 hr after injection, significant hyperintensity is
clearly observed in the ipsilateral LSN, which is maintained in the 24 hr image. External capsule
(EC, white arrowhead), one arm of the anterior commissure (AC, black arrowhead), and LSN
(gray arrowhead) are noted in the upper right panel. Bar = 1 mm.
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Figure 6. Mn2+ is transported to the contralateral hippocampus at 24 hr post-injection
MR images (coronal slices) taken from the same averaged 3D datasets as in Figure 5 but at the
level of the mid hippocampus (Bregma −2.7 mm) at the same four time points. The left panel
shows slices from the 2N littermates and right panel from the trisomics (Ts65DN). All images
are at the same spatial and intensity scales and have been rendered identically. By 0.5 hr after
injection (2nd row) signal increases are noted in portions of CA3 ipsilateral to the injection site.
By 6 hr after injection, significant hyperintensity is observed in much of the ipsilateral
hippocampus, while at 24 hr signal increases are observed in the contralateral hippocampus.
CA1 (white arrowhead), oriens layer (OR, black arrowhead) and molecular layer of the dentate
gyrus (MoDG, gray arrowhead) are noted in the lower right panel. Bar = 1 mm.
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Figure 7. Increased Mn2+ transport in the hippocampal-forebrain pathway is apparent in statistical
parametric mapping analysis of the MR data
Three views (top, side, end) of the same semitransparent volume projected into two dimensions
are shown. Colored voxels (red for 2N and blue for DS) are those places where the intensity
is significantly greater at the later time point (p<0.0005). Gray scale background is the 24-hour
average image. To appreciate the 3D data, please see Supplemental videos S1−6.
A. SPM of 0.5 hr versus pre-injection data. This map shows the cluster of Mn2+ enhanced
voxels at the injection site in the hippocampus of both genotypes. Scattered colored voxels
outside the injection sites are few and display no particular anatomical pattern. Note the absence
of voxels with significantly increased intensity in the hippocampal-septal pathway in this map
of 0.5 hr after injection over pre-injection. Also see Supplemental video S1 for 2N littermate,
and S2 for Ts65Dn.
B. SPM of 6 hr versus 0.5 hr post-injection data. At 6 hr post Mn2+ injection, the expected
pathway from hippocampus, along the fimbria, to the septal nuclei in both Ts65DN and 2N
littermates contains voxels with significantly increased intensity compared with the 0.5 hr post-
injection images. The extent of significantly enhanced voxels is substantially more pronounced
in the Ts65Dn. In the basal forebrain voxels with significantly increased intensity occupied
2.4 mm3 in the Ts65Dn group and only 1.3 mm3 in the 2N group. In the contralateral
hippocampus, voxels with significantly increased intensity occupied 0.4 mm3 in the Ts65Dn
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group and no significantly enhanced voxels were detected there in the 2N group. Also see
Supplemental video S3 for 2N littermate, and S4 for Ts65Dn.
C. SPM of 24 hr versus 6 hr post-injection data. Mn2+ transport continued along known
pathways from 6 to 24 hours with increased intensity in the septal regions and in the
hippocampus contralateral to the injection site in both cohorts and into a number of other
structures (see Table 1) in the Ts65Dn animals. In the basal forebrain, voxels with significantly
increased intensity occupied 1.6 mm3 in the Ts65Dn group and only 0.5 mm3 in the 2N group.
In the contralateral hippocampus, voxels with significantly increased intensity occupied 3.1
mm3 in the Ts65DN group 0.2 mm3 in the 2N group and. Also see Supplemental video S5 for
2N littermate, and S6 for Ts65Dn.
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Figure 8. Volume occupied by statistically enhanced voxels is greater in DS than in normal brains
Volumes within basal forebrain and hippocampus contralateral to the injection site occupied
by significantly enhanced voxels at 6 hr versus 0.5 hr (6 hr) and 24 hr versus 6 hr (24 hr) post-
injection are shown.
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